Holen Sie sich die Stockscreener-App
5.34
9.18%
-0.54
Handel nachbörslich:
5.00
-0.34
-6.37%
Schlusskurs vom Vortag:
$5.88
Offen:
$5.88
24-Stunden-Volumen:
42,225
Relative Volume:
1.06
Marktkapitalisierung:
$38.70M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.48M
KGV:
-5.1346
EPS:
-1.04
Netto-Cashflow:
$-28.71M
1W Leistung:
-31.19%
1M Leistung:
-17.85%
6M Leistung:
+6.59%
1J Leistung:
-69.44%
1-Tages-Spanne:
$5.02
$5.88
1-Wochen-Bereich:
$5.02
$7.9899
52-Wochen-Spanne:
$4.11
$28.68
Forte Biosciences Inc Stock (FBRX) Company Profile
Firmenname
Forte Biosciences Inc
Sektor
Branche
Telefon
(310) 618-6994
Adresse
3060 PEGASUS PARK DRIVE, DALLAS, CA
Vergleichen Sie FBRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FBRX
Forte Biosciences Inc
|
5.34 | 38.70M | 0 | -31.48M | -28.71M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.56 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.78 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
550.00 | 33.54B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.95 | 30.15B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
220.54 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-21 | Eingeleitet | TD Cowen | Buy |
| 2024-04-08 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2021-09-20 | Hochstufung | Chardan Capital Markets | Sell → Buy |
| 2021-09-03 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-09-03 | Herabstufung | Chardan Capital Markets | Buy → Sell |
| 2021-09-03 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2021-09-03 | Herabstufung | Truist | Buy → Hold |
| 2021-05-14 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-26 | Eingeleitet | Citigroup | Buy |
| 2020-08-28 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2020-08-25 | Eingeleitet | Truist | Buy |
Alle ansehen
Forte Biosciences Inc Aktie (FBRX) Neueste Nachrichten
Analysts Issue Forecasts for FBRX Q2 Earnings - Defense World
Equities Analysts Offer Predictions for FBRX FY2025 Earnings - Defense World
(FBRX) Investment Analysis - news.stocktradersdaily.com
All You Need to Know About Forte Biosciences (FBRX) Rating Upgrade to Buy - MSN
Forte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX) - Defense World
Chardan Capital Issues Pessimistic Forecast for Forte Biosciences (NASDAQ:FBRX) Stock Price - Defense World
Chardan Adjusts Price Target on Forte Biosciences to $61 From $64, Maintains Buy Rating - MarketScreener
Forte Biosciences Reports 2024 Progress and Financials - TipRanks
Is Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Forte's Celiac Treatment Shows Promise: Zero Dropouts and $58.4M War Chest - Stock Titan
Forte Biosciences, Inc. Announces Results and Provides Clinical Update - Bluefield Daily Telegraph
Forte Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Forte Biosciences Inc Files For Mixed Shelf Of Up To $300 MillionSEC Filing - MarketScreener
Forte Biosciences, Inc. SEC 10-K Report - TradingView
Forte Biosciences Inc. (FBRX) reports earnings - Quartz
(FBRX) Long Term Investment Analysis - news.stocktradersdaily.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
FORTE BIOSCIENCES Earnings Preview: Recent $FBRX Insider Trading, Hedge Fund Activity, and More - Nasdaq
Forte Biosciences (FBRX) to Release Earnings on Monday - The AM Reporter
Forte Biosciences Inc expected to post a loss of $3.27 a shareEarnings Preview - TradingView
Forte Biosciences, Inc. (NASDAQ:FBRX) Sees Large Drop in Short Interest - Defense World
Forte Biosciences (FBRX) Expected to Announce Quarterly Earnings on Monday - Defense World
Stock Traders Purchase Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - The AM Reporter
Traders Purchase High Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World
Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Update - MarketBeat
Forte Biosciences Stock Down 20% But Insiders Still In US$92k Profit - Simply Wall St
Pre-market Movers: ISPC, TH, IVVD, TOVX... - RTTNews
(FBRX) On The My Stocks Page - news.stocktradersdaily.com
Stock Traders Buy Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat
Evelo Biosciences Target of Unusually Large Options Trading (NASDAQ:EVLO) - Defense World
One Forte Biosciences Insider Raised Stake By 273% In Previous Year - Yahoo Finance
Best Stocks Under $20 Right Now - Benzinga
Where are the Opportunities in (FBRX) - Stock Traders Daily
Stock Traders Buy High Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat
Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - Defense World
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings -February 03, 2025 at 09:03 am EST - Marketscreener.com
Autoimmune Biotech Forte Lines Up Strategic Presentations at Major Healthcare Investment Forums - Stock Titan
(FBRX) Proactive Strategies - Stock Traders Daily
CSG Forte Wins TSG Real Transaction Metrics Awards for Second Consecutive Year - Yahoo Finance
Forte Biosciences expands equity incentive plan By Investing.com - Investing.com Australia
TD Cowen initiates Forte Biosciences stock with Buy rating - MSN
Forte Biosciences expands equity incentive plan - MSN
Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World
Meiwu Technology (NYSE:WNW) Stock Price Down 13.2% – Here’s Why - Defense World
Forte Biosciences (NASDAQ:FBRX) Coverage Initiated by Analysts at TD Cowen - Defense World
TD Cowen initiates Forte Biosciences stock with Buy rating By Investing.com - Investing.com Australia
Atopic Dermatitis Drugs Market Trends Analysis Report - GlobeNewswire
(FBRX) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Forte Biosciences Target of Unusually High Options Trading (NASDAQ:FBRX) - Defense World
Forte Biosciences (FBRX) Is a Great Choice for 'Trend' Investors, Here's Why - MSN
(FBRX) Technical Data - Stock Traders Daily
Finanzdaten der Forte Biosciences Inc-Aktie (FBRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Forte Biosciences Inc-Aktie (FBRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Wagner Paul A. | SEE REMARKS |
Apr 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
79,806 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Jan 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,151 |
| Wagner Paul A. | SEE REMARKS |
Jan 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
78,720 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Nov 21 '24 |
Buy |
5.55 |
22,514 |
124,998 |
30,776 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Oct 01 '24 |
Option Exercise |
0.00 |
375 |
0 |
8,395 |
| Wagner Paul A. | SEE REMARKS |
Oct 01 '24 |
Option Exercise |
0.00 |
1,250 |
0 |
77,568 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Jul 01 '24 |
Option Exercise |
0.00 |
9,375 |
0 |
203,849 |
| Wagner Paul A. | SEE REMARKS |
Jul 01 '24 |
Option Exercise |
0.00 |
31,250 |
0 |
1,910,424 |
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):